Veronica R. Holley

528 total citations
14 papers, 169 citations indexed

About

Veronica R. Holley is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Veronica R. Holley has authored 14 papers receiving a total of 169 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Veronica R. Holley's work include Cancer Genomics and Diagnostics (6 papers), Histiocytic Disorders and Treatments (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Veronica R. Holley is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Histiocytic Disorders and Treatments (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Veronica R. Holley collaborates with scholars based in United States. Veronica R. Holley's co-authors include Funda Meric‐Bernstam, Filip Jankú, Mark G. Erlander, Cecile Rose T. Vibat, Jason C. Poole, Razelle Kurzrock, Goran Cabrilo, José Baselga, Minal Patel and David M. Hyman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Veronica R. Holley

14 papers receiving 166 citations

Peers

Countries citing papers authored by Veronica R. Holley

Since Specialization

Citations

This map shows the geographic impact of Veronica R. Holley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica R. Holley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica R. Holley more than expected).

Fields of papers citing papers by Veronica R. Holley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronica R. Holley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica R. Holley. The network helps show where Veronica R. Holley may publish in the future.

Co-authorship network of co-authors of Veronica R. Holley

This figure shows the co-authorship network connecting the top 25 collaborators of Veronica R. Holley. A scholar is included among the top collaborators of Veronica R. Holley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronica R. Holley. Veronica R. Holley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: Phase 2 basket study. 2021 ·Journal of Clinical Oncology ·(unknown), Apostolia M. Tsimberidou, Veronica R. Holley, (unknown), Sapna P. Patel, Anil K. Sood, Anthony P. Conley, (unknown), Diane Healey, Vincent O’Neill, Filip Jankú	2
2	Dose‐escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF‐mutated advanced cancers 2020 ·Cancer ·Filip Jankú, Divya Sakamuri, Shumei Kato, Helen J. Huang, (unknown), Aung Naing, Veronica R. Holley, Sapna P. Patel, Rodabe N. Amaria, Gerald S. Falchook, Sarina A. Piha‐Paul, Ralph Zinner, Apostolia M. Tsimberidou, David S. Hong, Funda Meric‐Bernstam	9
3	Abstract 734: Monitoring of dynamic changes and clonal evolution in circulating tumor DNA from patients with IDH-mutated cholangiocarcinoma treated with IDH inhibitors 2020 ·Cancer Research ·Morten Lapin, Helen J. Huang, Milind Javle, Rachna T. Shroff, Shubham Pant, (unknown), (unknown), Veronica R. Holley, (unknown), Richard B. Lanman, Lawrence N. Kwong, Funda Meric‐Bernstam, Victoria M. Raymond, Filip Jankú	1
4	382 Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: phase 2 basket study 2020 ·SHILAP Revista de lepidopterología ·Filip Jankú, Apostolia M. Tsimberidou, Veronica R. Holley, (unknown), (unknown), (unknown), (unknown), Diane Healey, Vincent O’Neill	1
5	Abstract 2689: Overcoming BRAF/MEK resistance using vemurafenib with crizotinib or sorafenib in patients with BRAF-mutant advanced cancers: phase I study 2015 ·Cancer Research ·Shumei Kato, Aung Naing, Gerald S. Falchook, Veronica R. Holley, (unknown), Sapna P. Patel, Ralph Zinner, Sarina A. Piha‐Paul, Apostolia M. Tsimberidou, David S. Hong, Razelle Kurzrock, Funda Meric‐Bernstam, Filip Jankú	2
6	Prospective Blinded Study of BRAF V600E Mutation Detection in Cell-Free DNA of Patients with Systemic Histiocytic Disorders 2014 ·Cancer Discovery ·David M. Hyman, Eli L. Diamond, Cecile Rose T. Vibat, (unknown), Jason C. Poole, Minal Patel, Veronica R. Holley, Goran Cabrilo, Timothy T. Lu, Maria E. Arcila, Young Rock Chung, Raajit K. Rampal, Mario E. Lacouture, Neal Rosen, Funda Meric‐Bernstam, José Baselga, Razelle Kurzrock, Mark G. Erlander, Filip Jankú, Omar Abdel‐Wahab	84
7	BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease 2014 ·Oncotarget ·Filip Jankú, Cecile Rose T. Vibat, Karena Kosco, Veronica R. Holley, Goran Cabrilo, Funda Meric‐Bernstam, Vanda M. Stepanek, Patrick P. Lin, (unknown), (unknown), Jason C. Poole, Razelle Kurzrock, Mark G. Erlander	51
8	Detection of BRAF mutations in urine and plasma cell-free DNA: Application to the diagnosis and management of histiocytic disorder patients. 2014 ·Journal of Clinical Oncology ·Omar Abdel‐Wahab, Eli L. Diamond, Minal Patel, Veronica R. Holley, Goran Cabrilo, Raajit K. Rampal, (unknown), Karena Kosco, José Baselga, Razelle Kurzrock, Jason C. Poole, Cecile Rose T. Vibat, Mark G. Erlander, Filip Jankú, David M. Hyman	2
9	Longitudinal monitoring of BRAF V600E mutation in urinary cell-free DNA of patients with metastatic cancers. 2014 ·Journal of Clinical Oncology ·Filip Jankú, Cecile Rose T. Vibat, Gerald S. Falchook, Sarina A. Piha‐Paul, Aung Naing, Vivek Subbiah, Veronica R. Holley, Jennifer J. Wheler, Funda Meric‐Bernstam, Goran Cabrilo, Vanda M. Stepanek, Rajyalakshmi Luthra, (unknown), (unknown), Karena Kosco, Mark G. Erlander	2
10	Prospective Blinded Study of BRAFV600E Mutation Detection in Cell-Free DNA of Patients with Systemic Histiocytic Disorders 2014 ·Blood ·David M. Hyman, Eli L. Diamond, Cecile Rose T. Vibat, (unknown), Jason C. Poole, Minal Patel, Veronica R. Holley, Goran Cabrilo, Timothy T. Lu, Maria E. Arcila, Young Rock Chung, Raajit K. Rampal, Funda Meric‐Bernstam, José Baselga, Razelle Kurzrock, Mark G. Erlander, Filip Jankú, Omar Abdel‐Wahab	11
11	Abstract B26: Actionable mutations in cell-free DNA in plasma of patients with advanced cancers referred for experimental targeted therapies. 2013 ·Molecular Cancer Therapeutics ·Filip Jankú, Philipp Angenendt, Aung Naing, Gerald S. Falchook, Apostolia M. Tsimberidou, Veronica R. Holley, Siqing Fu, David S. Hong, Jennifer J. Wheler, Sarina A. Piha‐Paul, Ralph Zinner, Daniel D. Karp, Vivek Subbiah, Kevin B. Kim, Funda Meric‐Bernstam, Frank Diehl, Razelle Kurzrock	1
12	Abstract B177: Non-invasive tumor mutation detection of cell-free urinary DNA using massively parallel deep DNA sequencing. 2013 ·Molecular Cancer Therapeutics ·Jason C. Poole, Filip Jankú, Veronica R. Holley, Jennifer J. Wheler, Funda Meric‐Bernstam, (unknown), (unknown), (unknown), Karena Kosco, Mark G. Erlander	1
13	Abstract B175: Detection and monitoring of BRAF and KRAS mutations in cell-free urinary DNA of metastatic cancer patients by droplet digital PCR. 2013 ·Molecular Cancer Therapeutics ·Filip Jankú, Gerald S. Falchook, Sarina A. Piha‐Paul, Aung Naing, Apostolia M. Tsimberidou, Veronica R. Holley, Daniel D. Karp, Ralph Zinner, Siqing Fu, Jennifer J. Wheler, David S. Hong, Funda Meric‐Bernstam, Vanda M. Stepanek, (unknown), (unknown), (unknown), Karena Kosco, Jason C. Poole, Mark G. Erlander	1
14	BRAF mutation testing with a novel, rapid, fully automated molecular diagnostics prototype platform. 2013 ·Journal of Clinical Oncology ·Helen J. Huang, Benoit Devogelaere, Gerald S. Falchook, Siqing Fu, Laura S. Angelo, David S. Hong, Sarina A. Piha‐Paul, Aung Naing, Veronica R. Holley, Apostolia M. Tsimberidou, Vanda M. Stepanek, Kevin Kim, Vivek Subbiah, Jennifer J. Wheler, Ralph Zinner, Robert A. Wolff, Erwin Sablon, Geert Maertens, Razelle Kurzrock, Filip Jankú	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact